Aneurysmal subarachnoid hemorrhage is a condition wherein a brain aneurysm ruptures, resulting in bleeding into the subarachnoid space.
Market Analysis and Insights: Global Aneurysmal Subarachnoid Hemorrhage Market
In 2019, the global Aneurysmal Subarachnoid Hemorrhage market size was US$ 151.9 million and it is expected to reach US$ 175.3 million by the end of 2026, with a CAGR of 2.0% during 2021-2026.
Global Aneurysmal Subarachnoid Hemorrhage Scope and Market Size
Aneurysmal Subarachnoid Hemorrhage market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Aneurysmal Subarachnoid Hemorrhage market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Aneurysmal Subarachnoid Hemorrhage market is segmented into Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Lumbar Puncture, Xanthochromia, Cerebral Angiography, Transcranial Doppler Ultrasound, etc.
Segment by Application, the Aneurysmal Subarachnoid Hemorrhage market is segmented into Hospitals, Clinics, Others, etc.
Regional and Country-level Analysis
The Aneurysmal Subarachnoid Hemorrhage market is analysed and market size information is provided by regions (countries).
The key regions covered in the Aneurysmal Subarachnoid Hemorrhage market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Aneurysmal Subarachnoid Hemorrhage Market Share Analysis
Aneurysmal Subarachnoid Hemorrhage market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Aneurysmal Subarachnoid Hemorrhage business, the date to enter into the Aneurysmal Subarachnoid Hemorrhage market, Aneurysmal Subarachnoid Hemorrhage product introduction, recent developments, etc.
The major vendors include Edge Therapeutics, Actelion Pharmaceuticals, Arbor Pharmaceuticals, Mayfield Brain & Spine, Europa Group, GE, Philips, Siemens, Trivitron, Toshiba, etc.

This report focuses on the global Aneurysmal Subarachnoid Hemorrhage status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Aneurysmal Subarachnoid Hemorrhage development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Edge Therapeutics
Actelion Pharmaceuticals
Arbor Pharmaceuticals
Mayfield Brain & Spine
Europa Group
GE
Philips
Siemens
Trivitron
Toshiba

Market segment by Type, the product can be split into

Computed Tomography (CT) Scan
Magnetic Resonance Imaging (MRI)
Lumbar Puncture
Xanthochromia
Cerebral Angiography
Transcranial Doppler Ultrasound

Market segment by Application, split into

Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Aneurysmal Subarachnoid Hemorrhage status, future forecast, growth opportunity, key market and key players.
To present the Aneurysmal Subarachnoid Hemorrhage development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Aneurysmal Subarachnoid Hemorrhage are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.